The Swiss pharmaceutical group Roche underlined Friday that treatment of virulent bird flu in humans must be undertaken rapidly and probably with higher doses of the drug Tamiflu than for seasonal influenza.
Tamiflu maker underlines need for speed in bird flu treatment.